Q BioMed Profiled ON Proactive Investors

Q BioMed Inc. (OTCQB:QBIO) was recently featured on Proactive Investors where company CEO, Denis Corin talked about the company looking to the US Food and Drug Administration to sign off on “a new manufacturing facility to produce Strontium Chloride Sr89 injection.”

To watch the full interview, click here.
Click here to connect with Q BioMed and receive an Investor’s Presentation.

Source: www.proactiveinvestors.com